Interactive Session:
002. Controversies in Infection Prevention: Pro/Con
Wednesday, October 4, 2017: 1:30 PM-3:30 PM
Room: 06DE

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • describe the potential role that floors play in disease transmission in healthcare
  • describe how to prioritize CLABSI prevention resources
  • list pros and cons to adding the VAE measure to public reporting and payment programs

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, Hospital administrators, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Medical students and residents, Members-in-training, Microbiologists, Nurses, Pharmacists, Public health practitioners, Researchers, Scientists

Tracks: Adult ID, Epidemiology and Infection Control

Interactive Moderators:  Tara Palmore, MD, National Institutes of Health Clinical Center and Arjun Srinivasan, MD, FSHEA, Centers for Disease Control and Prevention

1:30 PM
The VAE Measure is Ready for Prime Time: Add it to CMS!
Marci Drees, MD, MS

Marin Kollef, MD, FACP, FCCP

2:10 PM
Floors Are an Important Reservoir for Cross- Transmission in Healthcare
Curtis J. Donskey, MD
Mark E. Rupp, MD, FIDSA, FSHEA

2:50 PM
How Low Can You Go (With CLABSI): Is there an Upper Limit to the Number Needed to Treat/Prevent?
Resource Allocation Should Match Risk
Lisa L. Maragakis, MD, MPH, FIDSA, FSHEA

Only Zero is Acceptable
Michael Bell, MD

CME Credits: Maximum of 2.00 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 2 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-220-L01-P


T. Palmore, None

A. Srinivasan, None

See more of: Interactive Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.